小RNA
鼻息肉
上皮-间质转换
生物
发病机制
污渍
细胞外小泡
癌症研究
分子生物学
免疫学
下调和上调
细胞生物学
基因
遗传学
作者
Xuan Wang,Rui Zheng,Liang Wu,H Qiu,Tingting Yuan,Weizong Wang,Huan Deng,Weijia Kong,Jian Chen,Yongheng Bai,Yinghui Li,Yuxia Chen,Qingyu Wu,Shaohuan Wu,Xuhua Huang,Zhenshan Shi,Qiang Fu,Shouxin Zhang,Qintai Yang
出处
期刊:Rhinology
[Rhinology]
日期:2024-04-01
被引量:1
摘要
BACKGROUND: Epithelial-mesenchymal transition (EMT) plays a crucial role in the pathogenesis of chronic rhinosinusitis with nasal polyps (CRSwNP). However, the involvement of small extracellular vesicles (sEVs) in EMT and their contributions to CRSwNP has not been extensively investigated. METHODS: SEVs were isolated from nasal mucosa through ultracentrifugation. MicroRNA sequencing and reverse-transcription quantitative polymerase chain reaction were employed to analyze the differential expression of microRNAs carried by sEVs. Human nasal epithelial cells (hNECs) were used to assess the EMT-inducing effect of sEVs/microRNAs. EMT-associated markers were detected by western blotting and immunofluorescence. Dual-luciferase reporter assay was performed to determine the target gene of miR-375-3p. MicroRNA mimic, lentiviral, and plasmid transduction were used for functional experiments. RESULTS: In line with the greater EMT status in eosinophilic CRSwNP (ENP), sEVs derived from ENP (ENP-sEVs) could induce EMT in hNECs. MiR-375-3p was elevated in ENP-sEVs compared to that in control and nonENP. MiR-375- 3p carried by ENP-sEVs facilitated EMT by directly targeting KH domain containing RNA binding (QKI) at seed sequences of 913-919, 1025-1033, and 2438-2444 in 3’-untranslated region. Inhibition of QKI by miR-375-3p overexpression promoted EMT, which could be reversed by restoration of QKI. Furthermore, the abundance of miR-375-3p in sEVs was closely correlated with the clinical symptom score and disease severity. CONCLUSIONS:MiR-375-3p-enriched sEVs facilitated EMT by suppressing QKI in hNECs. The association of miR-375-3p with disease severity underscores its potential as both a diagnostic marker and a therapeutic target for the innovative management of CRSwNP.
科研通智能强力驱动
Strongly Powered by AbleSci AI